Yuji Kashiwakura Selected Research

Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)

6/2012

Il2rg gene-targeted severe combined immunodeficiency pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuji Kashiwakura Research Topics

Disease

11	Neoplasms (Cancer) 07/2012 - 06/2005
8	Hemophilia A (Haemophilia) 05/2013 - 01/2006
4	Hemorrhage 05/2013 - 08/2008
3	Infections 09/2021 - 01/2005
3	Prostatic Neoplasms (Prostate Cancer) 10/2008 - 06/2005
2	Hemophilia B (Haemophilia B) 03/2013 - 06/2010
2	Sepsis (Septicemia) 04/2011 - 01/2006
2	Disseminated Intravascular Coagulation 04/2011 - 01/2006
1	Hypersensitivity (Allergy) 05/2014
1	Disease Susceptibility (Diathesis) 05/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2012
1	Inflammation (Inflammations) 09/2011
1	Anemia 09/2011
1	Bacterial Infections (Bacterial Infection) 09/2011
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2010
1	Brain Infarction 12/2008
1	Ischemia 12/2008
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2008
1	Rare Diseases (Rare Disease) 03/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2007
1	Acute Kidney Injury (Acute Renal Failure) 01/2006
1	Thrombotic Thrombocytopenic Purpura 01/2006
1	Renal Insufficiency (Renal Failure) 01/2006
1	Vascular Diseases (Vascular Disease) 11/2004
1	Atherosclerosis 11/2004
1	Thromboembolism 04/2004
1	Vascular System Injuries 02/2002
1	Hyperplasia 02/2002

Drug/Important Bio-Agent (IBA)

4	Factor VIII (Coagulation Factor VIII)IBA 05/2013 - 01/2006
4	Proteins (Proteins, Gene)FDA Link 08/2011 - 06/2005
3	Blood Coagulation Factors (Coagulation Factor)IBA 03/2013 - 08/2008
2	Neutralizing AntibodiesIBA 09/2021 - 08/2008
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 03/2013 - 06/2010
2	tumor-associated transplantation antigen (TSTA)IBA 07/2012 - 10/2011
2	LuciferasesIBA 07/2012 - 10/2011
2	Leukocyte Elastase (Neutrophil Elastase)IBA 09/2011 - 04/2011
2	FibrinIBA 04/2011 - 04/2004
2	Dacarbazine (DIC)FDA LinkGeneric 04/2011 - 01/2006
2	AntigensIBA 08/2008 - 07/2006
1	nanolucIBA 09/2021
1	Interleukin-5 (Interleukin 5)IBA 05/2014
1	Factor VII (Proconvertin)IBA 05/2013
1	Blood Proteins (Serum Proteins)IBA 03/2013
1	Green Fluorescent ProteinsIBA 07/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2011
1	Dyneins (Dynein)IBA 08/2011
1	Fibrin Fibrinogen Degradation ProductsIBA 04/2011
1	Fibrinolysin FDA Link 04/2011
1	VinculinIBA 10/2010
1	Small Interfering RNA (siRNA)IBA 10/2010
1	Interleukin-7 (Interleukin 7)IBA 05/2009
1	Therapeutic UsesIBA 05/2009
1	InterleukinsIBA 05/2009
1	JTE 013IBA 12/2008
1	Chemotactic FactorsIBA 12/2008
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2008
1	Amino Acids FDA Link 10/2008
1	PolymersIBA 10/2008
1	Phosphotransferases (Kinase)IBA 10/2008
1	Messenger RNA (mRNA)IBA 10/2008
1	Factor VIIa (Activated Factor VII)IBA 08/2008
1	Thrombin FDA Link 08/2008
1	Hemostatics (Antihemorrhagics)IBA 08/2008
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2007
1	JNK Mitogen-Activated Protein KinasesIBA 07/2007
1	ADAMTS13 ProteinIBA 01/2006
1	AutoantibodiesIBA 01/2006
1	CreatinineIBA 01/2006
1	Peptide Hydrolases (Proteases)FDA Link 01/2006
1	thiamine triphosphorate (TTP)IBA 01/2006
1	Actins (F Actin)IBA 01/2006
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2006
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 06/2005
1	SERPIN-B5 (maspin)IBA 06/2005
1	integrin alphaVbeta5IBA 01/2005
1	Proto-Oncogene Proteins c-metIBA 01/2005
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2005
1	Dynamin IIIBA 11/2004
1	oxidized low density lipoproteinIBA 11/2004
1	CollagenIBA 02/2002

Therapy/Procedure

4	Therapeutics 03/2013 - 08/2008
3	Transplantation 10/2010 - 07/2006
1	Heterologous Transplantation (Xenotransplantation) 06/2012
1	Injections 10/2008
1	Intramuscular Injections 01/2006
1	Intravenous Injections 01/2006
1	Aftercare (After-Treatment) 06/2005